19 results for author:"Zhu C.Q." in Literature citations
Results Customize
› Repeat search in UniProtKB (28)
| Development and characterization of 109 polymorphic EST-SSRs derived from the Chinese bayberry (Myrica rubra, Myricaceae) transcriptome. Zhang S.Y., Li X., Feng C., Zhu C.Q., Grierson D., Xu C.J., Chen K.S. Am. J. Bot. 99:e501-7(2012) · UniProtKB (22) |
| L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer. Hai J., Zhu C.Q., Bandarchi B., Wang Y.H., Navab R., Shepherd F.A., Jurisica I., Tsao M.S. Clin. Cancer Res. 18:1914-1924(2012) · Mapped (13) |
| Interaction between MYC and MCL1 in the genesis and outcome of non-small-cell lung cancer. Allen T.D., Zhu C.Q., Jones K.D., Yanagawa N., Tsao M.S., Bishop J.M. Cancer Res. 71:2212-2221(2011) · Mapped (13) |
| Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma. Lockwood W.W., Chari R., Coe B.P., Thu K.L., Garnis C., Malloff C.A., Campbell J., Williams A.C., Hwang D., Zhu C.Q. et al. PLoS Med. 7:e1000315-e1000315(2010) · Mapped (2) |
| Chronic restraint stress alters the expression and distribution of phosphorylated tau and MAP2 in cortex and hippocampus of rat brain. Yan J., Sun X.B., Wang H.Q., Zhao H., Zhao X.Y., Xu Y.X., Guo J.C., Zhu C.Q. Brain Res. 1347:132-141(2010) · Mapped (4) |
| Intrathecal cytokine and chemokine profiling in neuropsychiatric lupus or lupus complicated with central nervous system infection. Lu X.Y., Zhu C.Q., Qian J., Chen X.X., Ye S., Gu Y.Y. Lupus 19:689-695(2010) · Mapped (3) |
| Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells. Navab R., Liu J., Seiden-Long I., Shih W., Li M., Bandarchi B., Chen Y., Lau D., Zu Y.F., Cescon D. et al. Neoplasia 11:1292-1300(2009) · Mapped (30) |
| SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Bass A.J., Watanabe H., Mermel C.H., Yu S., Perner S., Verhaak R.G., Kim S.Y., Wardwell L., Tamayo P., Gat-Viks I. et al. Nat. Genet. 41:1238-1242(2009) · Mapped (1) |
| Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21. Zhu C.Q., da Cunha Santos G., Ding K., Sakurada A., Cutz J.C., Liu N., Zhang T., Marrano P., Whitehead M., Squire J.A. et al. J. Clin. Oncol. 26:4268-4275(2008) · Mapped (26) |
| Gab1 but not Grb2 mediates tumor progression in Met overexpressing colorectal cancer cells. Seiden-Long I., Navab R., Shih W., Li M., Chow J., Zhu C.Q., Radulovich N., Saucier C., Tsao M.S. Carcinogenesis 29:647-655(2008) · Mapped (30) |
| Three-gene prognostic classifier for early-stage non small-cell lung cancer. Lau S.K., Boutros P.C., Pintilie M., Blackhall F.H., Zhu C.Q., Strumpf D., Johnston M.R., Darling G., Keshavjee S., Waddell T.K. et al. J. Clin. Oncol. 25:5562-5569(2007) · Mapped (16) |
| Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer. Tsao M.S., Aviel-Ronen S., Ding K., Lau D., Liu N., Sakurada A., Whitehead M., Zhu C.Q., Livingston R., Johnson D.H. et al. J. Clin. Oncol. 25:5240-5247(2007) · Mapped (40) |
| KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer. Corson T.W., Zhu C.Q., Lau S.K., Shepherd F.A., Tsao M.S., Gallie B.L. Clin. Cancer Res. 13:3229-3234(2007) · Mapped (1) |
| Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma. Ford C.E., Lau S.K., Zhu C.Q., Andersson T., Tsao M.S., Vogel W.F. Br. J. Cancer 96:808-814(2007) · Mapped (12) |
| Okadaic acid induced cyclin B1 expression and mitotic catastrophe in rat cortex. Chen B., Cheng M., Hong D.J., Sun F.Y., Zhu C.Q. Neurosci. Lett. 406:178-182(2006) · Mapped (2) |
| Dynamic changes of phosphorylated tau in mouse hippocampus after cold water stress. Feng Q., Cheng B., Yang R., Sun F.Y., Zhu C.Q. Neurosci. Lett. 388:13-16(2005) · Mapped (5) |
| Skp2 gene copy number aberrations are common in non-small cell lung carcinoma, and its overexpression in tumors with ras mutation is a poor prognostic marker. Zhu C.Q., Blackhall F.H., Pintilie M., Iyengar P., Liu N., Ho J., Chomiak T., Lau D., Winton T., Shepherd F.A. et al. Clin. Cancer Res. 10:1984-1991(2004) · Mapped (2) |
| Interaction with general transcription factor IIF (TFIIF) is required for the suppression of activated transcription by RPB5-mediating protein (RMP). Wei W., Gu J.X., Zhu C.Q., Sun F.Y., Dorjsuren D., Lin Y., Murakami S. Cell Res. 13:111-120(2003) · UniProtKB (3) |
| [Aberrant neuronal expression of mitotic protein, tau and Bax in the rat brain after injection of Abeta(25-35) into the amygdala]. Hong D.J., Pei A.L., Sun F.Y., Zhu C.Q. Sheng Li Xue Bao 55:142-146(2003) · Mapped (7) |